XIENCE V Everolimus Eluting Coronary Stent System (EECSS) USA Post-Approval Study
ID Number 08-0656Principal Investigator(s)
Samin K. Sharma
Department(s) or Division(s)
This is a prospective, open-label, multi-center, observational, single arm registry designed to evaluate XIENCE V EECSS continued safety and effectiveness on subjects for clinical use (after FDA approval). Only XIENCE V EECSS stents are received during procedure (stent placement for blockages in blood vessels).
Recruiting Patients: No